Pine Haven Investment Counsel’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Pine Haven Investment Counsel's IDXX Position: Q2 2026 in Review
Pine Haven Investment Counsel increased its Idexx Laboratories (IDXX) stake by 4.8% in Q2 2026, buying an estimated $35.3K and bringing the position to 1,388 shares worth $731K. The position accounts for 0.49% of the portfolio, ranked #57.
Pine Haven Investment Counsel first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $885K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Pine Haven Investment Counsel held 1,388 shares of Idexx Laboratories worth $731K as of Q2 2026.
- Pine Haven Investment Counsel bought 63 Idexx Laboratories shares in Q2 2026, an estimated $35.3K.
- Idexx Laboratories made up 0.49% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #57 holding.
- Pine Haven Investment Counsel first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
- Pine Haven Investment Counsel's Idexx Laboratories position peaked at $885K in Q4 2025.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.